SynthesisHealth research policy and systems2022
A systematic review of the literature on the impact of the Seguro Popular.
Synthesis in Health research policy and systems, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Financial protection in flux: longitudinal evidence on out-of-pocket spending among middle-aged and older Mexicans during the 'Seguro Popular'-INSABI transition.Health policy and planning · 2026Article
- Evidence speaks beyond conceptual frameworks.Lancet regional health. Americas · 2026Article
- Beyond numbers: the missing conceptual foundation in evaluating Mexico's health system performance.Lancet regional health. Americas · 2026Article
- Changes in health insurance coverage and healthcare utilization of middle-aged and older adults after the transition from Seguro Popular to INSABI.BMC health services research · 2025Article
- Measuring impacts: a scoping review of healthcare impact evaluations.Health research policy and systems · 2025Article
- A dynamic microsimulation of health outcomes in Mexico's aging population.The Gerontologist · 2025Article
- Why expanding public health insurance coverage is not enough to provide effective ambulatory care: policy lessons from Mexico, 2000-2022.Journal of public health policy · 2025Article
- Surgical delay in appendicitis among children: the role of social vulnerability.Frontiers in pediatrics · 2025Article
- Impact of Government-Funded Health Insurance on Out-of-Pocket Expenditure and Quality of Hospital-Based Care in Indian States of Madhya Pradesh and Maharashtra.Applied health economics and health policy · 2024Article
- Population-level trends in self-reported healthcare utilization among older adults in Mexico with and without cognitive impairment.BMC geriatrics · 2024Article
- Breastfeeding among women employed in Mexico's informal sector: strategies to overcome key barriers.International journal for equity in health · 2024Article
- Equity in out-of-pocket health expenditure: Evidence from a health insurance program reform in Mexico.Journal of global health · 2023Article
- The Impact of Seguro Popular on the Progression of Disabilities Among Older Adults With Chronic Degenerative Diseases in Mexico.Research on agingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Seguro Popular (SP) was launched in 2004 to increase access to healthcare and reduce catastrophic expenditures among the Mexican population. To document the evidence on its effectiveness, we conducted a systematic review of impact evaluations of the SP.
methodsWe included papers using rigorous quasi-experimental designs to assess the effectiveness of the SP. We evaluated the quality of each study and presented the statistical significance of the effects by outcome category.
resultsWe identified 26 papers that met the inclusion criteria. Sixteen studies that evaluated the impact of SP on financial protection found consistent and statistically significant positive effects in 55% of the 65 outcomes analyzed. Nine studies evaluating utilization of health services for the general and infant populations found effectiveness on 40% of 30 outcomes analyzed. Concerning screening services for hypertension, diabetes, and cervical and prostate cancer, we found three studies evaluating 14 outcomes and finding significant effects on 50% of them. Studies looking at the impact of SP on diabetes, hypertension, and general health care and treatment evaluated 19 outcomes and found effects on 21% of them. One study assessed five diabetes monitoring services and found positive effects on four of them. The only study on morbidity and mortality found positive results on three of the four outcomes of interest.
conclusionWe found mixed evidence on the impact of SP on financial protection, healthcare utilization, morbidity and mortality. In the 26 studies included in this review, researchers found positive effects in roughly half of the outcomes and null results on the rest.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.